{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:47:27Z","timestamp":1785847647045,"version":"3.56.0"},"reference-count":84,"publisher":"American Chemical Society (ACS)","issue":"15","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00242339"],"award-info":[{"award-number":["RS-2023-00242339"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00245466"],"award-info":[{"award-number":["RS-2023-00245466"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00402984"],"award-info":[{"award-number":["RS-2024-00402984"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00513291"],"award-info":[{"award-number":["RS-2025-00513291"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>Conspectus<\/jats:title>\n                  <jats:p>Boron neutron capture therapy (BNCT) is a radiotherapeutic modality in which biological selectivity is dictated not by targeting alone but by the spatial control of nuclear reactions. Following tumor-selective accumulation of 10B, neutron irradiation induces the 10B(n,\u03b1)7Li reaction, generating high\u2013linear energy transfer particles with micrometer path lengths that confine cytotoxicity to boron-enriched cells. Despite its intrinsic precision, the clinical translation of BNCT has long been hindered by a fundamental chemical challenge: the inability to achieve sufficient, homogeneous, and durable intratumoral boron distribution. In this Account, we argue that BNCT must be reframed as a problem of chemical architecture across length scales, rather than a simple paradigm of boron delivery followed by irradiation. Building on foundational contributions from Jin-Ho Choy (layered double hydroxide\u2013based confinement and ion-exchange systems), Hiroyuki Nakamura (molecular boron design enabling targeting and functional integration), and Koji Ono (clinical dosimetry and translational constraints), we outline how nanohybrid platforms transform BNCT into an integrated systems therapy in which materials design, biological transport, and radiation physics are co-optimized. We identify three governing design principles for next-generation BNCT. First, structural confinement and high-density boron loading enabled by layered inorganic hosts, carborane clusters, and hybrid nanocarriers, ensure sufficient payload delivery at the cellular and subcellular levels. Second, spatiotemporal control of boron distribution, achieved through surface engineering, targeting ligands, and microenvironment-responsive release, addresses the critical challenge of intratumoral heterogeneity. Third, integration with imaging and dosimetry establishes a \u201cmeasure-what-you-treat\u201d paradigm, linking molecular design directly to therapeutic outcome. We further highlight that BNCT efficacy is governed not by bulk tumor boron concentration alone but by microdistribution and subcellular localization, reflecting the short path length of high-linear energy transfer(LET) particles. This insight shifts design strategies from maximizing systemic delivery toward controlling intracellular fate and spatial precision. In parallel, the transition to accelerator-based neutron sources imposes additional constraints on boron chemistry, necessitating higher delivery efficiency and tighter coordination between pharmacokinetics and irradiation conditions. Together, these advances position BNCT as a chemically programmable precision radiotherapy, in which therapeutic outcome is dictated by the hierarchical organization of boron from molecular to nanoscale to clinical dimensions. Future progress will depend on scalable chemical design, quantitative imaging of boron distribution, and integration with emerging therapeutic modalities. We propose that the next phase of BNCT will be defined by the convergence of nanochemistry, systems-level transport control, and clinically informed design, enabling broader translation into refractory and heterogeneous cancers.<\/jats:p>","DOI":"10.1021\/acs.accounts.6c00253","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:04:09Z","timestamp":1784725449000},"page":"2336-2347","source":"Crossref","is-referenced-by-count":0,"title":["Chemical Programming\nof Intratumoral Boron for Boron\nNeutron Capture Therapy"],"prefix":"10.1021","volume":"59","author":[{"given":"Sanoj Rejinold","family":"N","sequence":"first","affiliation":[{"name":"Dankook University , , ,","place":["Cheonan, Korea, 31116"]},{"name":"Dankook University , , ,","place":["Cheonan, Korea, 31116"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goeun","family":"Choi","sequence":"additional","affiliation":[{"name":"Dankook University , , ,","place":["Cheonan, Korea, 31116"]},{"name":"Institute for Convergence Science (ICS), Global Chemical Convergence Research Institute (GCCRI), Dankook University , ,","place":["Cheonan, Korea, 31116"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ono","sequence":"additional","affiliation":[{"name":"BNCT Joint Clinical Institute, Osaka Medical and Pharmaceutical University , , ,","place":["Takatsuki, Osaka, Japan, 569-8686"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-2984","authenticated-orcid":true,"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Institute of Science Tokyo , , 4259 Nagatsuta-cho Midori-ku , , ,","place":["Yokohama, Japan, 226-8501"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4149-7100","authenticated-orcid":true,"given":"Jin-Ho","family":"Choy","sequence":"additional","affiliation":[{"name":"Dankook University , , ,","place":["Cheonan, Korea, 31116"]},{"name":"The National Academy of Sciences , , ,","place":["Seoul, Republic of Korea, 06579"]},{"name":"Dankook University , , \u00a0 ,","place":["Cheonan, Korea, 31116"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"27","key":"2026080408064549100_cit1","doi-asserted-by":"publisher","first-page":"1704470","DOI":"10.1002\/adfm.201704470","article-title":"Highly Condensed\nBoron Cage Cluster Anions in 2D Carrier and Its Enhanced Antitumor\nEfficiency for Boron Neutron Capture Therapy","volume":"28","author":"Choi","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"2026080408064549100_cit2","doi-asserted-by":"publisher","first-page":"114566","DOI":"10.1016\/j.jconrel.2025.114566","article-title":"Alanine-serine-cysteine\ntransporter-targeted small-molecule boron carriers for neutron capture\ntherapy of L-4-boronophenylalanine-refractory tumors","volume":"390","author":"Miura","year":"2026","journal-title":"J. Control.Release"},{"issue":"5","key":"2026080408064549100_cit3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/jjco\/hyac004","article-title":"Boron neutron capture therapy and add-on bevacizumab in patients\nwith recurrent malignant glioma","volume":"52","author":"Furuse","year":"2022","journal-title":"Jpn. J. Clin.\nOncol."},{"key":"2026080408064549100_cit4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jconrel.2023.06.022","article-title":"Efficient neutron capture therapy of glioblastoma with\npteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid\n(PBC-IP)","volume":"360","author":"Nishimura","year":"2023","journal-title":"J. Control. Release"},{"key":"2026080408064549100_cit5","doi-asserted-by":"publisher","first-page":"42158","DOI":"10.1021\/acsnano.5c12640","article-title":"Coupling Adoptive Cell Therapy with Boron Neutron\nCapture Therapy: Using Functional Tumor-Infiltrating Lymphocytes for\nTumor Delivery of Boron Carbide Nanoparticles","volume":"19","author":"Demichelis","year":"2025","journal-title":"ACS Nano"},{"issue":"1","key":"2026080408064549100_cit6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.7150\/thno.123376","article-title":"State-of-the-art boron\nclusters for boron neutron-capture therapy","volume":"16","author":"Wang","year":"2026","journal-title":"Theranostics"},{"issue":"11","key":"2026080408064549100_cit7","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3390\/ph18111739","article-title":"Borylated 5-Membered Ring Iminosugars: Synthesis and\nBiological Evaluation for Glycosidase Inhibition and Anticancer Properties\nfor Application in Boron Neutron Capture Therapy (BNCT)-Part 2","volume":"18","author":"Prichard","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"12","key":"2026080408064549100_cit8","doi-asserted-by":"publisher","DOI":"10.1002\/mp.70100","article-title":"Enhanced difference\nghost shuffle U-Net: A hybrid Monte Carlo deep learning denoiser for\nboron neutron capture therapy dose calculation","volume":"52","author":"Wang","year":"2025","journal-title":"Med. Phys."},{"issue":"12","key":"2026080408064549100_cit9","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.70392","article-title":"Enhancement of dose distribution using tissue compensators\nin boron neutron capture therapy","volume":"26","author":"Sasaki","year":"2025","journal-title":"J. Appl. Clin\nMed. Phys."},{"issue":"12","key":"2026080408064549100_cit10","doi-asserted-by":"publisher","DOI":"10.1002\/mp.70156","article-title":"Clinical feasibility\nof a commercial bolus in boron neutron capture therapy: Dosimetric\nevaluation and activation risk","volume":"52","author":"Takeuchi","year":"2025","journal-title":"Med. Phys."},{"key":"2026080408064549100_cit11","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1007\/s00259-025-07668-3","article-title":"A LAT1-selective PET\ntracer, 5-[(1)(8)F]F-alphaMe-3BPA, as a companion\nto its structurally matched (1)(0)B analog in boron neutron capture\ntherapy","volume":"53","author":"Kondo","year":"2026","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2026080408064549100_cit12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1601013","article-title":"Boron neutron\ncapture therapy in the context of tumor\nheterogeneity: progress, challenges, and future perspectives","volume":"15","author":"Zhou","year":"2025","journal-title":"Front. Oncol."},{"key":"2026080408064549100_cit13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1485207","article-title":"Boron neutron capture therapy for melanoma: recent advances and future\nprospects","volume":"15","author":"Sun","year":"2025","journal-title":"Front .Oncol."},{"key":"2026080408064549100_cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2024.215795","article-title":"Novel\npromising boron agents for boron neutron capture therapy: Current\nstatus and outlook on the future","volume":"511","author":"Xu","year":"2024","journal-title":"Coord. Chem.\nRev."},{"key":"2026080408064549100_cit15","doi-asserted-by":"publisher","DOI":"10.1016\/j.inoche.2023.111318","article-title":"Boron neutron capture\ntherapy anti-tumor effect of nanostructured boron carbon nitride:\nA new potential candidate","volume":"157","author":"Kaur","year":"2023","journal-title":"Inorg. Chem. Commun."},{"issue":"2","key":"2026080408064549100_cit16","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1679","article-title":"Recent progress\nin layered double hydroxides as a cancer\ntheranostic nanoplatform","volume":"13","author":"Choi","year":"2021","journal-title":"WIREs Nanomed.Nanobiotechnol."},{"issue":"1","key":"2026080408064549100_cit17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13550-025-01199-6","article-title":"Unravelling physical and radiobiological effects\nof proton boron fusion reaction with anionic metallacarboranes ([o-COSAN]-)\nin breast cancer cells","volume":"15","author":"Belchior","year":"2025","journal-title":"EJNMMI Research"},{"key":"2026080408064549100_cit18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jconrel.2024.06.006","article-title":"Active control of pharmacokinetics\nusing light-responsive polymer-drug conjugates for boron neutron capture\ntherapy","volume":"371","author":"Tokura","year":"2024","journal-title":"J. Control.Release"},{"issue":"1","key":"2026080408064549100_cit19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1021\/bc300527n","article-title":"Development\nof high boron content liposomes and their\npromising antitumor effect for neutron capture therapy of cancers","volume":"24","author":"Koganei","year":"2013","journal-title":"Bioconjug Chem."},{"issue":"19","key":"2026080408064549100_cit20","doi-asserted-by":"publisher","first-page":"9039","DOI":"10.1073\/pnas.89.19.9039","article-title":"Model studies directed\ntoward the boron neutron-capture\ntherapy of cancer: boron delivery to murine tumors with liposomes","volume":"89","author":"Shelly","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"2026080408064549100_cit21","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1073\/pnas.92.5.1367","article-title":"Selective\nboron delivery to murine\ntumors by lipophilic species incorporated in the membranes of unilamellar\nliposomes","volume":"92","author":"Feakes","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026080408064549100_cit22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.actbio.2025.07.009","article-title":"Nanocarrier-driven neutron capture\ntherapy: Strategies and perspectives","volume":"203","author":"Wu","year":"2025","journal-title":"Acta Biomater"},{"issue":"35","key":"2026080408064549100_cit23","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405158","article-title":"Boron Neutron Capture\nTherapy-Derived Extracellular Vesicles via\nDNA Accumulation Boost Antitumor Dendritic Cell Vaccine Efficacy","volume":"11","author":"Lv","year":"2024","journal-title":"Adv. Scie."},{"issue":"1","key":"2026080408064549100_cit24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40880-018-0299-7","article-title":"Boron delivery\nagents for neutron capture therapy of\ncancer","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun."},{"issue":"5","key":"2026080408064549100_cit25","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1021\/acs.biomac.6b01845","article-title":"Carborane\nDerivative Conjugated with Gold Nanoclusters for Targeted Cancer Cell\nImaging","volume":"18","author":"Wang","year":"2017","journal-title":"Biomacromolecules"},{"key":"2026080408064549100_cit26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102660","article-title":"Recent advances in cancer\nnanomedicine: From smart\ntargeting to personalized therapeutics - pioneering a new era in precision\noncology","volume":"36","author":"Younas","year":"2026","journal-title":"Mater.Today Bio"},{"issue":"4","key":"2026080408064549100_cit27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.7150\/ntno.95251","article-title":"Peptide Conjugated\nBoron Neutron Capture Therapy for\nEnhanced Tumor Targeting","volume":"8","author":"Jyothi","year":"2024","journal-title":"Nanotheranostics"},{"issue":"1","key":"2026080408064549100_cit28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.colsurfa.2005.06.075","article-title":"Novel organic\u2013inorganic\nhybrid mesoporous materials\nfor boron adsorption","volume":"275","author":"Wang","year":"2006","journal-title":"Colloids Surf. A."},{"issue":"24","key":"2026080408064549100_cit29","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202100969","article-title":"Exosome-Coated 10B Carbon Dots for Precise\nBoron Neutron Capture Therapy in a Mouse Model of Glioma In Situ","volume":"31","author":"Li","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"2026080408064549100_cit30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1186\/s12885-016-2913-x","article-title":"Comparison\nof the pharmacokinetics between L-BPA and\nL-FBPA using the same administration dose and protocol: a validation\nstudy for the theranostic approach using [(18)F]-L-FBPA positron emission\ntomography in boron neutron capture therapy","volume":"16","author":"Watanabe","year":"2016","journal-title":"BMC Cancer"},{"issue":"7","key":"2026080408064549100_cit31","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1158\/0008-5472.CAN-05-1742","article-title":"Improvement of the Tumor-Suppressive Effect of Boron Neutron Capture\nTherapy for Amelanotic Melanoma by Intratumoral Injection of the Tyrosinase\nGene","volume":"66","author":"Morita","year":"2006","journal-title":"Cancer Res."},{"key":"2026080408064549100_cit32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21037\/tro.2018.04.04","article-title":"Prof. Koji\nOno: A pioneer of clinical applications of BNCT devoted to exploring\nits new possibilities","volume":"2","author":"Yu","year":"2018","journal-title":"Therapeutic Radiology\nand Oncology"},{"issue":"5","key":"2026080408064549100_cit33","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.apradiso.2004.05.059","article-title":"Effectiveness\nof BNCT for Recurrent Head and Neck Malignancies","volume":"61","author":"Kato","year":"2004","journal-title":"Appl. Radiat. Isot."},{"issue":"8659","key":"2026080408064549100_cit34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0140-6736(89)90567-9","article-title":"Treatment of malignant\nmelanoma by\nsingle thermal neutron capture therapy with melanoma-seeking 10B-compound","volume":"334","author":"Mishima","year":"1989","journal-title":"Lancet"},{"issue":"5","key":"2026080408064549100_cit35","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ijrobp.2008.08.024","article-title":"Early\nPrediction of Outcome in Advanced Head-and-Neck\nCancer Based on Tumor Blood Volume Alterations During Therapy: A Prospective\nStudy","volume":"72","author":"Cao","year":"2008","journal-title":"International Journal of Radiation Oncology,\nBiology, Physics"},{"issue":"11","key":"2026080408064549100_cit36","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7250","article-title":"Preliminary outcomes\nof boron neutron\ncapture therapy for head and neck cancers as a treatment covered by\npublic health insurance system in Japan: Real-world experiences over\na 2-year period","volume":"13","author":"Takeno","year":"2024","journal-title":"Cancer Medicine"},{"issue":"1","key":"2026080408064549100_cit37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/neuonc\/noab108","article-title":"Reactor-based boron\nneutron capture therapy for 44 cases of recurrent and refractory high-grade\nmeningiomas with long-term follow-up","volume":"24","author":"Takai","year":"2022","journal-title":"Neuro\nOncol."},{"key":"2026080408064549100_cit38","doi-asserted-by":"publisher","first-page":"112044","DOI":"10.1016\/j.apradiso.2025.112044","article-title":"Boron Nanodrugs\nfor Boron Neutron Capture Therapy","volume":"225","author":"Wan","year":"2025","journal-title":"Appl. Radiat.\nIsot."},{"issue":"5","key":"2026080408064549100_cit39","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1021\/bc060064k","article-title":"Transferrin-Loaded\nnido-Carborane Liposomes: Tumor-Targeting\nBoron Delivery System for Neutron Capture Therapy","volume":"17","author":"Miyajima","year":"2006","journal-title":"Bioconjugate Chem."},{"issue":"2","key":"2026080408064549100_cit40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1021\/ol062840+","article-title":"Synthesis of Boron\nCluster Lipids: closo-Dodecaborate as an Alternative Hydrophilic Function\nof Boronated Liposomes for Neutron Capture Therapy","volume":"9","author":"Lee","year":"2007","journal-title":"Org. Lett."},{"issue":"10","key":"2026080408064549100_cit41","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/ph18101491","article-title":"Assessment of Carrier-Free Metallacarboranes for Targeted Radiation\nTherapies PBFT and BNCT: Comparative Cellular Effects and Dosimetry\nStudies with [o-FESAN]\u2013 in Breast Cancer Cells","volume":"18","author":"Di Maria","year":"2025","journal-title":"Pharmaceuticals"},{"key":"2026080408064549100_cit42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jconrel.2016.07.017","article-title":"Maleimide-functionalized closo-dodecaborate albumin\nconjugates (MID-AC): Unique ligation at cysteine and lysine residues\nenables efficient boron delivery to tumor for neutron capture therapy","volume":"237","author":"Kikuchi","year":"2016","journal-title":"J. Control.Release"},{"issue":"10","key":"2026080408064549100_cit43","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1021\/acs.molpharmaceut.0c00478","article-title":"Cyclic RGD-Functionalized\ncloso-Dodecaborate\nAlbumin Conjugates as Integrin Targeting Boron Carriers for Neutron\nCapture Therapy","volume":"17","author":"Kawai","year":"2020","journal-title":"Mol. Pharm."},{"issue":"1","key":"2026080408064549100_cit44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.canlet.2015.10.004","article-title":"L-phenylalanine preloading\nreduces the 10B(n, \u03b1)7Li\ndose to the normal brain by inhibiting the uptake of boronophenylalanine\nin boron neutron capture therapy for brain tumours","volume":"370","author":"Watanabe","year":"2016","journal-title":"Cancer Lett."},{"issue":"8","key":"2026080408064549100_cit45","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1021\/acsnano.5c22264","article-title":"Structure-to-Therapeutic\nTransformation of Nanohydrogels Triggers\nCalcium Overload for Potentiated Boron Neutron Capture Therapy","volume":"20","author":"Yang","year":"2026","journal-title":"ACS Nano"},{"key":"2026080408064549100_cit46","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202504325","article-title":"Portable\nDevice for Wound Care: An Electrosprayable Zinc Basic Salt-Tranexamic\nAcid Nanohybrid System","volume":"15","author":"Shao","year":"2026","journal-title":"Adv. Healthc Mater."},{"issue":"36","key":"2026080408064549100_cit47","doi-asserted-by":"publisher","first-page":"40901","DOI":"10.1021\/acsomega.5c01703","article-title":"Transport\nMechanisms of 2D Nanoparticles across a Human Follicle-Associated\nEpithelium Model","volume":"10","author":"Rejinold","year":"2025","journal-title":"ACS Omega"},{"key":"2026080408064549100_cit48","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202505711","article-title":"J. H. 2D van\nder Waals System Integrated\nwith Targeting Radio-Diagnostic and Imaging Functions","author":"Eom","year":"2025","journal-title":"Small"},{"issue":"37","key":"2026080408064549100_cit49","doi-asserted-by":"publisher","first-page":"21458","DOI":"10.1039\/D5NR02201K","article-title":"Transforming\ndocetaxel delivery: lung-targeted polyphosphazene nanoparticles with\nenhanced safety profile","volume":"17","author":"Rejinold","year":"2025","journal-title":"Nanoscale"},{"issue":"1","key":"2026080408064549100_cit50","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.1038\/s41467-025-62423-4","article-title":"A randomized, double-blind, placebo-controlled trial\nof niclosamide nanohybrid for the treatment of patients with mild\nto moderate COVID-19","volume":"16","author":"Kim","year":"2025","journal-title":"Nat. Commun."},{"issue":"30","key":"2026080408064549100_cit51","doi-asserted-by":"publisher","first-page":"11515","DOI":"10.1021\/acs.nanolett.5c02826","article-title":"A Strategic\nAntimetastatic Solution\nfor Bone-Targeting Prostate Cancer via Nanoengineered Niclosamide","volume":"25","author":"Rejinold","year":"2025","journal-title":"Nano Lett."},{"issue":"27","key":"2026080408064549100_cit52","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202410345","article-title":"Transforming Niclosamide\nthrough Nanotechnology: A Promising Approach for Long COVID Management","volume":"21","author":"Rejinold N","year":"2025","journal-title":"Small"},{"key":"2026080408064549100_cit53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.142488","article-title":"Durable\nfibrous nanohybrid sunscreen films with in-situ fabricated enteromorpha\npolysaccharides for enhanced UV protection","volume":"308","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"14","key":"2026080408064549100_cit54","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202404818","article-title":"Harnessing\nNanohybridized Niclosamide\nfor Precision Mpox Therapeutics","volume":"14","author":"Rejinold","year":"2025","journal-title":"Adv. Healthc.\nMater."},{"issue":"3","key":"2026080408064549100_cit55","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1039\/D4NH00497C","article-title":"Revolutionizing\nhealthcare: inorganic medicinal nanoarchitectonics for advanced theranostics","volume":"10","author":"Yu","year":"2025","journal-title":"Nanoscale Horiz."},{"issue":"46","key":"2026080408064549100_cit56","doi-asserted-by":"publisher","first-page":"14541","DOI":"10.1021\/acs.nanolett.4c02845","article-title":"Insight\ninto Preventing Global Dengue\nSpread: Nanoengineered Niclosamide for Viral Infections","volume":"24","author":"Rejinold","year":"2024","journal-title":"Nano Lett."},{"issue":"30","key":"2026080408064549100_cit57","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1039\/D4TB00813H","article-title":"A functionalized\ncell membrane biomimetic nanoformulation based on layered double hydroxide\nfor combined tumor chemotherapy and sonodynamic therapy","volume":"12","author":"Li","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"39","key":"2026080408064549100_cit58","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202305148","article-title":"The Next Generation\nCOVID-19 Antiviral; Niclosamide-Based\nInorganic Nanohybrid System Kills SARS-CoV-2","volume":"20","author":"Choi","year":"2024","journal-title":"Small"},{"key":"2026080408064549100_cit59","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113386","article-title":"Curcumin in exfoliated\nlayered double hydroxide nanoparticles: Pre-clinical evaluation as\nlung cancer nanomedicine","volume":"228","author":"Rejinold","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"6","key":"2026080408064549100_cit60","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/nano13061102","article-title":"Multifunctional\nLayered Double Hydroxides\nfor Drug Delivery and Imaging","volume":"13","author":"Yu","year":"2023","journal-title":"Nanomaterials"},{"issue":"24","key":"2026080408064549100_cit61","doi-asserted-by":"publisher","first-page":"15993","DOI":"10.3390\/ijms232415993","article-title":"Polyphosphazene-Based\nBiomaterials\nfor Biomedical Applications","volume":"23","author":"Jin","year":"2022","journal-title":"Int.J.Mol.Sci."},{"issue":"22","key":"2026080408064549100_cit62","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.3390\/polym14224839","article-title":"Multifunctional\nPolymeric Micelles\nfor Cancer Therapy","volume":"14","author":"Jin","year":"2022","journal-title":"Polymers"},{"issue":"3","key":"2026080408064549100_cit63","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1039\/D2TB02121H","article-title":"NOAEL cancer therapy:\na tumor targetable docetaxel-inorganic polymer nanohybrid prevents\ndrug-induced neutropenia","volume":"11","author":"Jin","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"19","key":"2026080408064549100_cit64","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/polym14194110","article-title":"Effects of Nanofillers\nBased on Cetyltrimethylammonium-Modified\nClays in a Polypropylene Nanocomposite","volume":"14","author":"Ryu","year":"2022","journal-title":"Polymers\n(Basel)"},{"issue":"19","key":"2026080408064549100_cit65","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.3390\/molecules27196439","article-title":"pH-Responsive\nInorganic\/Organic Nanohybrids System\nfor Controlled Nicotinic Acid Drug Release","volume":"27","author":"Yu","year":"2022","journal-title":"Molecules"},{"issue":"19","key":"2026080408064549100_cit66","doi-asserted-by":"publisher","first-page":"11862","DOI":"10.3390\/ijms231911862","article-title":"Bio-Inorganic Layered Double Hydroxide\nNanohybrids in Photochemotherapy: A Mini Review","volume":"23","author":"Rejinold","year":"2022","journal-title":"Int.J.Mol.Sci."},{"issue":"20","key":"2026080408064549100_cit67","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.1039\/D2BM00879C","article-title":"Artesunate drug-loaded 2D nano-shuttle\nlanding on RBCs infected with malaria parasites","volume":"10","author":"Kim","year":"2022","journal-title":"Biomater Sci."},{"issue":"45","key":"2026080408064549100_cit68","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.1039\/D2TB01165D","article-title":"Dilute\nlattice doping of (64)Cu into\n2D-nanoplates: its impact on radio-labeling efficiency and stability\nfor target selective PET imaging","volume":"10","author":"Eom","year":"2022","journal-title":"J. Mater.\nChem. B"},{"issue":"1","key":"2026080408064549100_cit69","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/14686996.2022.2052181","article-title":"The emergence of nanoporous materials in lung\ncancer therapy","volume":"23","author":"Radhakrishnan","year":"2022","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"5","key":"2026080408064549100_cit70","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s42860-021-00153-6","article-title":"Niclosamide-Exfoliated\nAnionic Clay Nanohybrid Repurposed as an Antiviral Drug for Tackling\nCovid-19; Oral Formulation with Tween 60\/Eudragit S100","volume":"69","author":"Rejinold","year":"2021","journal-title":"Clays. Clay Miner."},{"key":"2026080408064549100_cit71","doi-asserted-by":"publisher","DOI":"10.1016\/j.micromeso.2021.111394","article-title":"Niclosamide encapsulated\nin mesoporous silica and geopolymer:\nA potential oral formulation for COVID-19","volume":"326","author":"Piao","year":"2021","journal-title":"Microporous\nMesoporous Mater."},{"key":"2026080408064549100_cit72","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.112063","article-title":"Injectable\nniclosamide nanohybrid as an anti-SARS-CoV-2 strategy","volume":"208","author":"Rejinold","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"14","key":"2026080408064549100_cit73","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.3390\/ma14143792","article-title":"Bovine Serum Albumin-Coated\nNiclosamide-Zein Nanoparticles as Potential Injectable Medicine against\nCOVID-19","volume":"14","author":"Rejinold","year":"2021","journal-title":"Materials"},{"issue":"14","key":"2026080408064549100_cit74","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.1039\/D0SC06724E","article-title":"Inorganic-inorganic\nnanohybrids for drug delivery, imaging and photo-therapy: recent developments\nand future scope","volume":"12","author":"Choi","year":"2021","journal-title":"Chem. Sci."},{"issue":"6","key":"2026080408064549100_cit75","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1021\/ja981823f","article-title":"Intercalative\nNanohybrids of Nucleoside Monophosphates and DNA in Layered Metal\nHydroxide","volume":"121","author":"Choy","year":"1999","journal-title":"J. Am. Chem. Soc."},{"issue":"22","key":"2026080408064549100_cit76","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1002\/1521-3773(20001117)39:22&lt;4041::AID-ANIE4041&gt;3.0.CO;2-C","article-title":"Inorganic Layered\nDouble Hydroxides as Nonviral Vectors","volume":"39","author":"Choy","year":"2000","journal-title":"Angew.\nChem., Int. Ed."},{"issue":"14","key":"2026080408064549100_cit77","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1002\/ange.201510844","article-title":"Biodegradable inorganic\nnanovector: passive versus active tumor targeting in siRNA transportation","volume":"128","author":"Park","year":"2016","journal-title":"Angew. Chem."},{"issue":"5\u20136","key":"2026080408064549100_cit78","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jpcs.2006.01.033","article-title":"Efficient delivery\nof anticancer drug MTX through MTX-LDH\nnanohybrid system","volume":"67","author":"Oh","year":"2006","journal-title":"J. Phys. Chem. Solids"},{"issue":"6","key":"2026080408064549100_cit79","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1021\/bc0601323","article-title":"Cellular\nuptake\nmechanism of an inorganic nanovehicle and its drug conjugates: enhanced\nefficacy due to clathrin-mediated endocytosis","volume":"17","author":"Oh","year":"2006","journal-title":"Bioconjugate Chem."},{"key":"2026080408064549100_cit80","doi-asserted-by":"publisher","first-page":"40","DOI":"10.21037\/tro.2018.09.04","article-title":"Prospects\nfor the new era of boron neutron capture therapy and subjects for\nthe future","volume":"2","author":"Ono","year":"2018","journal-title":"Ther. Radiol. Oncol."},{"issue":"1","key":"2026080408064549100_cit81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17974-7","article-title":"Improvement in the neutron beam collimation for application in boron\nneutron capture therapy of the head and neck region","volume":"12","author":"Hu","year":"2022","journal-title":"Sci. Rep."},{"key":"2026080408064549100_cit82","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.radonc.2020.11.001","article-title":"Boron\nneutron capture\ntherapy using cyclotron-based epithermal neutron source and borofalan\n((10)B) for recurrent or locally advanced head and neck cancer (JHN002):\nAn open-label phase II trial","volume":"155","author":"Hirose","year":"2021","journal-title":"Radiother. Oncol."},{"key":"2026080408064549100_cit83","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2025.112152","article-title":"Boron\nneutron capture therapy (BNCT) phase\nI clinical trial for newly diagnosed glioblastoma by newly developed\naccelerator at University of Tsukuba","volume":"226","author":"Nakai","year":"2025","journal-title":"Appl.Radiat.\nIsot"},{"key":"2026080408064549100_cit84","first-page":"349","article-title":"Two-Step Rate Infusion of 4-Borono-l-Phenylalanine\n(BPA) Solution in BPA-BNCT (Ono\u2019s Method). Annex XIII","volume-title":"Advances in Boron Neutron Capture Therapy","author":"Ono","year":"2023"}],"container-title":["Accounts of\nChemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.accounts.6c00253","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/59\/15\/2336\/66124421\/acs.accounts.6c00253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/59\/15\/2336\/66124421\/acs.accounts.6c00253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:13:46Z","timestamp":1785845626000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/achre4\/article\/59\/15\/2336\/5226789\/Chemical-Programming-of-Intratumoral-Boron-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":84,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,7,22]]},"published-print":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.accounts.6c00253","relation":{},"ISSN":["0001-4842","1520-4898"],"issn-type":[{"value":"0001-4842","type":"print"},{"value":"1520-4898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}